Genoptix, Inc. Announces National Three-Year Agreement With Aetna

CARLSBAD, Calif., Feb 25, 2010 /PRNewswire via COMTEX/ -- Genoptix, Inc. (Nasdaq: GXDX) today announced that it will participate in Aetna's (AET) national provider network to offer specialized laboratory and comprehensive diagnostic services designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma.

Back to news